EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 9

Stinging nettle Urtica dioica L.

Also called: nettle, nettle root, nettle leaf

Stinging nettle (Urtica dioica) is a tall herb of temperate, humid regions. Two different materials are sold: the root, studied for urinary symptoms of benign prostatic hyperplasia, and the leaves and flowering parts, promoted for other uses.

Category
Botanical
Part used
Root (prostate studies); leaf, herb or herb top (other uses)
Strongest evidence
B Some positive trials
Native range
Native range (WCVP checklist record via GBIF): Europe to Siberia and W. China, NW. Africa
Reviewed
2026-10-30

Class 1 Well studied in people. A 2020 meta-analysis pooled 8 RCTs (401 participants) of nettle (Urtica dioica) supplementation in adults with type 2 diabetes. [3]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Stinging nettle does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Stinging nettle, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Root: lower urinary tract symptoms of benign prostatic hyperplasia (regulatory assessment)CEMA's herbal committee (2025) found eight randomized, double-blind, placebo-controlled root trials but judged them inadequate to prove efficacy: short, small, poorly defined preparations. It accepted traditional use only. [1]
Root extract trials in men with benign prostatic hyperplasiaBLiverTox summarizes a 52-week trial (226 men, 429 mg root extract) with slightly larger symptom-score gains than placebo (-5.7 vs -4.8) and a 558-man crossover trial reporting 81% vs 16% improvement. [2]
Blood glucose in adults with type 2 diabetes (nettle supplementation)BA 2020 meta-analysis of 8 RCTs (401 participants) found lower fasting blood sugar (-18.01 mg/dl) but no significant change in insulin, HOMA-IR or HbA1c; heterogeneity was high. [3]
Leaf: hay fever, arthritis, high blood pressure and other promoted usesCLiverTox states leaf extracts are promoted for these and other conditions, but human controlled trials have not substantiated the claims. [2]

Main constituents: Root: lectins (about 0.05-0.6%, e.g. Urtica dioica agglutinin, UDA), lignans, sterols, phenylpropanes, ceramides, triterpenes, tannins and coumarins [1]; Fresh leaf: stinging hairs that inject histamine, acetylcholine and other irritants; processing destroys the hairs [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Root extract 429 mg for 52 weeks (226-man BPH trial); 500 mg three times daily for three months in a 92-patient type 2 diabetes trial. [2]
  • Over-the-counter capsules, tablets and solutions are typically 300 to 600 mg daily. [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated March 3, 2023).

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada monograph contraindication: 'Do not use if you are pregnant or breastfeeding.'

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    None reported

    Medicines (general): EMA root monograph (2025), interactions: 'None reported.'

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    3 statements

    EMA, nettle root monograph (Revision 1, adopted January 22, 2025), traditional use: 2 g of comminuted root in 150 ml of water as a herbal infusion, …

    Details and sources
  • Generally well tolerated; possible headache, nausea, diarrhea, constipation and abdominal discomfort. LiverTox likelihood score E (unlikely cause of clinically apparent liver injury); no published cases of liver injury from root or leaf extracts. [2]
  • Fresh leaves cause skin stinging and urticaria that can last up to 24 hours; LiverTox advises against taking raw leaves by mouth. [2]
  • Root (EMA): nausea, heartburn, feeling of fullness, flatulence, diarrhea and allergic reactions (pruritus, rash, urticaria), frequency not known; see a doctor if fever, spasms or blood in the urine occur. [4]
  • Leaf (EMA): contraindicated where reduced fluid intake is recommended (e.g. severe cardiac or renal disease); use during pregnancy and lactation is not recommended; not established under 12 years. [5]
  • Health Canada lists pregnancy and breastfeeding as contraindications: 'Do not use if you are pregnant or breastfeeding.' [6]
Interactions

Interactions

Known interactions of Stinging nettle
WithWhat happens
Medicines (general)EMA's root monograph states interactions: 'None reported.' [4]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • EMA (2025): no pharmacopoeia monographs exist for the root preparations; the European Pharmacopoeia defines the root herbal substance as dried, whole or fragmented underground parts, and several trial preparations were not adequately characterized. [1]
Regulation

Regulatory status

  • US: No NDI notification naming stinging nettle (Urtica dioica) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [7]
  • US: LiverTox states stinging nettle is not approved for any medical condition in the United States. [2]
  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [9]
  • EU: EMA herbal monograph on nettle root (Revision 1, adopted January 22, 2025): traditional herbal medicinal product for relief of lower urinary tract symptoms related to benign prostatic hyperplasia. [4]
  • EU: EMA herbal monograph on nettle leaf (adopted January 14, 2010): traditional use for relief of minor articular pain and to increase urine amount to flush the urinary tract. [5]
  • Canada: Health Canada's Stinging Nettle monograph (March 27, 2026) covers herb top (diuretic, rheumatic complaints, nutritive tonic, seasonal allergy claims) and root (difficulty in urination in early benign prostatic hyperplasia). [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Root: lectins (about 0.05-0.6%, e.g. Urtica dioica agglutinin, UDA) and lignans Lectins (proteins) and lignans [P1]
  • Root: sterols (phytosterols about 0.01%, considered the least important), with phenylpropanes, ceramides, triterpenes, tannins and coumarins Sterols and mixed phenolics [P1]
  • Root: LiverTox states the active ingredient responsible for effects on urinary symptoms is unknown Not identified [P2]
  • Fresh leaf stinging hairs: histamine, acetylcholine and other irritants (destroyed by processing) Amines [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming stinging nettle (Urtica dioica) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC evaluation of stinging nettle (Urtica dioica) was found (IARC Monographs list of classifications, list data last updated 2026-07-23, checked 2026-10-29). [P4]
  • No NTP technical report on stinging nettle (Urtica dioica) was found (NTP technical reports list checked 2026-10-29). [P5]

Liver (NIH LiverTox)

  • LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated March 3, 2023). No published cases of serum enzyme elevations or clinically apparent liver injury from root or leaf extracts; prospective studies that monitored liver tests found no change. [P2]

Interactions with medicines

  • Medicines (general): EMA root monograph (2025), interactions: 'None reported.' [P6]
  • Medicines (general): EMA leaf monograph (2010), interactions: 'None reported.' [P9]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P7]
  • Plant-part identity (root versus leaf or herb) against the European Pharmacopoeia definition — Root and leaf are different materials with separate EMA monographs and uses; the European Pharmacopoeia defines the root herbal substance as dried, whole or fragmented underground parts, and EMA found several trial preparations inadequately characterized. [P1]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P8]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EMA, nettle root monograph (Revision 1, adopted January 22, 2025), traditional use: 2 g of comminuted root in 150 ml of water as a herbal infusion, 2-3 times daily; long-term use is possible; no relevant use under 18 years. [P6]
  • EMA, nettle leaf monograph (adopted January 14, 2010), traditional use: 2-4 g as a single dose for herbal tea, 3-6 times daily; liquid extract (1:5) 30-40 drops 3-4 times daily; dry extract (4.7-6:1) 750 mg 2-3 times daily. [P9]
  • Health Canada, Stinging Nettle monograph (March 27, 2026), adults 18 and older: 1.2-18 g dried herb tops per day; 0.3-24 g dried root per day (difficulty in urination, early benign prostatic hyperplasia). [P10]

Pregnancy and breastfeeding

  • Health Canada monograph contraindication: 'Do not use if you are pregnant or breastfeeding.' [P10]
  • EMA leaf monograph: safety during pregnancy and lactation has not been established; use during pregnancy and lactation is not recommended. [P9]

Sources for this profile

  1. European Medicines Agency, HMPC. Assessment report on Urtica dioica L.; Urtica urens L., radix, Revision 1 (EMA/HMPC/322627/2023; dated 22 January 2025), 2025-01-22. ema.europa.eu
  2. NIH LiverTox (NIDDK). Stinging Nettle (Last Update: March 3, 2023), 2023-03-03. ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. IARC Monographs. List of Classifications (list data last updated 2026-07-23; retrieved October 29, 2026), 2026-10-29. monographs.iarc.who.int
  5. National Toxicology Program. Technical Reports (list retrieved October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
  6. European Medicines Agency, HMPC. European Union herbal monograph on Urtica dioica L.; Urtica urens L., radix, Revision 1 (EMA/HMPC/322646/2023; adopted 22 January 2025), 2025-01-22. ema.europa.eu
  7. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of October 23, 2026), 2026-10-23. ecfr.gov
  8. GBIF species API: IUCN Red List category for Urtica dioica L. (usageKey 7960979), 2026-10-29. api.gbif.org
  9. European Medicines Agency, HMPC. Community herbal monograph on Urtica dioica L.; Urtica urens L., folium (EMA/HMPC/508015/2007; adopted 14 January 2010), 2010-01-14. ema.europa.eu
  10. Health Canada, NNHPD. Monograph: Stinging Nettle - Urtica dioica (dated March 27, 2026), 2026-03-27. webprod.hc-sc.gc.ca
Sources

Sources

  1. European Medicines Agency, HMPC. Assessment report on Urtica dioica L.; Urtica urens L., radix, Revision 1 (EMA/HMPC/322627/2023; dated 22 January 2025), 2025-01-22. ema.europa.eu
  2. NIH LiverTox (NIDDK). Stinging Nettle (Last Update: March 3, 2023), 2023-03-03. ncbi.nlm.nih.gov
  3. Ziaei R, Foshati S, Hadi A, et al. The effect of nettle (Urtica dioica) supplementation on the glycemic control of patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Phytother Res 2020;34(2):282-294 (PMID 31802554), 2020-02. pubmed.ncbi.nlm.nih.gov
  4. European Medicines Agency, HMPC. European Union herbal monograph on Urtica dioica L.; Urtica urens L., radix, Revision 1 (EMA/HMPC/322646/2023; adopted 22 January 2025), 2025-01-22. ema.europa.eu
  5. European Medicines Agency, HMPC. Community herbal monograph on Urtica dioica L.; Urtica urens L., folium (EMA/HMPC/508015/2007; adopted 14 January 2010), 2010-01-14. ema.europa.eu
  6. Health Canada, NNHPD. Monograph: Stinging Nettle - Urtica dioica (dated March 27, 2026), 2026-03-27. webprod.hc-sc.gc.ca
  7. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  8. GBIF species API: WCVP checklist record for Urtica dioica L. (key 207861338; native range remark 'Europe to Siberia and W. China, NW. Africa'), 2026-10-29. api.gbif.org
  9. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.